Fenghuang Zhan, M.D., Ph.D. Assistant Professor of Medicine
Ph.D. , Cancer Research Institute, Hunan Medical University, Changsha,
Hunan, China Master of Oral Pathoogy and Oral Maxiolofacial Surgery, Stomatology Faculty,
Hunan Medical University M.D., Hunan Medical University Postdoctoral fellowships, Department of Anatomical Sciences and
Neurobiology, University of Louisville, KY, and Myeloma Institute for
Research and Therapy, UAMS
Selected Publications:
Zhan F, Hardin J, Bumm K, Zheng M, Tian E, Sanderson R, Yang Y, Wilson C, Zangari M, Anaissie E, Morris C, Muwalla F, Van Rhee F, Fassas A, Tricot G, Crowley J, Barlogie B, and Shaughnessy J. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance and normal bone marrow plasma cells. Blood, 2002; 99:1745-57.
Zhan F, Erming Tian, Bumm K, Smith R, Barlogie B, and Shaughnessy J. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood. 2003;101:1128-40.
Tian E, Zhan F(co-1st author), Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.N Engl J Med. 2003 349:2483-94.
Zhan F, Barlogie B and Shaughnessy Jr. J. Toward the Identification Distinct Molecular and Clinical Entities of Multiple Myeloma Using Global Gene Expression Profiling. Semin Hematol. 2003 40: 308-20.
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.